All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| RLMD / Relmada Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RLMD / Relmada Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
| KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NSPR / InspireMD, Inc.
|
|
|
|
|
|
|
|
| OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
| CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
| MYO / Myomo, Inc.
|
|
|
|
|
|
|
|
| OWLT / Owlet, Inc.
|
|
|
|
|
|
|
|
| CYBN / Cybin Inc.
|
|
|
|
|
|
|
|
| FENC / Fennec Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ACOG / Alpha Cognition Inc.
|
|
|
|
|
|
|
|
| PROF / Profound Medical Corp.
|
|
|
|
|
|
|
|
| OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
| VERU / Veru Inc.
|
|
|
|
|
|
|
|
| FBIO / Fortress Biotech, Inc.
|
|
|
|
|
|
|
|
| ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| NAMS / NewAmsterdam Pharma Company N.V.
|
|
|
|
|
|
|
|
| KIORA PHARMACEUTICALS INC
/ (49721T309) |
|
|
|
|
|
|
|
| CYBN / Cybin Inc.
|
|
|
|
|
|
|
|
| VOR / Vor Biopharma Inc.
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
| OCUL / Ocular Therapeutix, Inc.
|
|
|
|
|
|
|
|
| BFRI / Biofrontera Inc.
|
|
|
|
|
|
|
|
| MDWD / MediWound Ltd.
|
|
|
|
|
|
|
|
| PYPD / PolyPid Ltd.
|
|
|
|
|
|
|
|
| CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| LXRX / Lexicon Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| OUTLOOK THERAPEUTICS INC
/ (69012T206) |
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| SPDR SER TR
/ PUT Put (78464A950) |
|
|
|
|
|
|
|
| NEUMORA THERAPEUTICS INC.
/ PUT Put (640979950) |
|
|
|
|
|
|
|
| BIOMEA FUSION INC
/ PUT Put (09077A956) |
|
|
|
|
|
|
|
| CANDEL THERAPEUTICS INC
/ PUT Put (137404959) |
|
|
|
|
|
|
|
| EDGEWISE THERAPEUTICS INC
/ PUT Put (28036F955) |
|
|
|
|
|
|
|
| INVESCO QQQ TR
/ PUT Put (46090E953) |
|
|
|
|
|
|
|
| CLSD / Clearside Biomedical, Inc.
|
|
|
|
|
|
|
|
| KPRX / Kiora Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
| URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
| SAVA / Cassava Sciences, Inc. Put
|
|
|
|
|
|
|
|
| DCTH / Delcath Systems, Inc.
|
|
|
|
|
|
|
|
| VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
| CLRB / Cellectar Biosciences, Inc.
|
|
|
|
|
|
|
|
| TLPH / Talphera, Inc.
|
|
|
|
|
|
|
|
| XERS / Xeris Biopharma Holdings, Inc.
|
|
|
|
|
|
|
|
| OEF / iShares Trust - iShares S&P 100 ETF Put
|
|
|
|
|
|
|
|
| XNTK / SPDR Series Trust - SPDR NYSE Technology ETF Call
|
|
|
|
|
|
|
|
| CRMD / CorMedix Inc.
|
|
|
|
|
|
|
|
| CRMD / CorMedix Inc. Call
|
|
|
|
|
|
|
|
| QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
| SAVA / Cassava Sciences, Inc.
|
|
|
|
|
|
|
|
| REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
